Gemphire Therapeutics Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Michigan
THIS EMPLOYMENT AGREEMENT (this “Agreement”) by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”) and JEFFREY S. MATHIESEN (the “Executive”) is signed by the Company and the Executive on April 15, 2016, and is made effective as of the IPO Date (the “Effective Date”).
INDEMNIFICATION AGREEMENT Effective Date: , 2016Indemnification Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”), is made as of the Effective Date set forth above, between GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”), whose address is 43334 Seven Mile Road, Suite 1000, Northville, Michigan 48167, and [INSERT NAME] (“Indemnitee”).
GEMPHIRE THERAPEUTICS INC. FORM OF NOTE PURCHASE AGREEMENT JOINDER AGREEMENTJoinder Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations
THIS JOINDER AGREEMENT (this “Joinder Agreement”) is made as of December , 2015, by and among GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”), and the individual or entity listed on the signature page attached hereto (the “Purchaser”).
FORM OF NOTE PURCHASE AGREEMENTNote Purchase Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Michigan
This Note is issued pursuant to the terms of that certain Note Purchase Agreement, dated as of July 31, 2015 (the “Note Purchase Agreement”), among the Company and, among others, the Holder and is entitled to the benefit thereof. Capitalized terms used herein without definition shall have the respective meanings ascribed to them in the Note Purchase Agreement.
GEMPHIRE THERAPEUTICS INC. INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Michigan
THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of March 31, 2015 by and among GEMPHIRE THERAPEUTICS INC., a Delaware corporation (the “Company”), and the Investors listed on EXHIBIT A attached to this Agreement (collectively, the “Investors” and each, without distinction among them, an “Investor”).
OFFICE SPACE SUBLEASE AGREEMENTOffice Space Sublease Agreement • April 18th, 2016 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • Michigan
This OFFICE SPACE SUBLEASE AGREEMENT (this “Agreement”) is dated and effective as of January 1, 2015 (“Effective Date”), by and MICHIGAN LIFE VENTURES, LLC a Michigan limited liability company with offices located at 43334 Seven Mile Road, Suite 100, Northville, MI 48167 (“MLV”), and, Gemphire Therapeutics Inc. a Delaware corporation with offices located at 43334 Seven Mile Road, Suite 1000, Northville, MI 48167 (“GEMPHIRE”).
